Ticker: ZURA

Zura Bio Limited (NASDAQ: ZURA) - Snapshot What's happening inside: Zura is heavily ramping clinical activity - initiating TibuSHIELD (Phase 2 HS) in May 2025 and running TibuSURE (Phase 2 SSc) started Dec 2024 - and funding that buildout with equity financings and ATM sales. Management says exis...

Zura Bio Limited (NASDAQ: ZURA) has recently reported its financial performance for the first quarter of 2025, highlighting both successes and challenges as it continues to develop its clinical-stage product candidates. Income Statement Overview: Operating Expenses: Total operating expenses surg...